Cannabinoids have established themselves as therapeutic options in the treatment of pain in recent years. Nevertheless, patients can experience problems when using them, particularly with regard to tolerance. A new aqueous nanodispersion appears to be able to eliminate these problems.
Autoren
- Jens Dehn
Publikation
- InFo RHEUMATOLOGIE
Related Topics
You May Also Like
- AI-supported imaging and new biomarkers
CHD diagnostics update
- Bipolar disorder, anxiety disorder, depression
Lurasidone as monotherapy for bipolar I depression with anxiety symptoms
- Arterial hypertension: ESC guideline 2024 in focus
New category “elevated blood pressure” – what are the therapeutic implications?
- Low-grade pediatric gliomas
Consideration of the tumor microenvironment opens up new treatment options
- Palliative care symptom and needs assessment.
What screening tools are helpful?
- Patient-centered rounds in medicine
Aligning care with the patient
- HIV: antiretroviral therapy (ART)
Single-tablet regimens support adherence
- Rare pulmonary syndromes